NanoMicro Tech released an earnings forecast, expecting attributable net profit for the first half of 2026 to be between 128 million and 150 million yuan, a year-on-year increase of 102% to 137%. Revenue for the same period is expected to be between 558 million and 572 million yuan, up 35% to 38% year-on-year. Deducted non-recurring attributable net profit is expected to be between 120 million and 140 million yuan, a rise of 117% to 153%. The company said it is actively seizing opportunities from the explosive growth of small nucleic acid drugs and the domestic substitution of insulin chromatography packing. Revenue growth from its core chromatography packing and chromatography media products is expected to exceed 50%. Through comprehensive budget management, total expenses excluding the impact of share-based payments are expected to increase by less than 8%. In the first quarter of this year, the company achieved revenue of 253 million yuan and attributable net profit of 68.13 million yuan.
Suzhou Nanomicro Technology Co LtdCompany expects attributable net profit to rise 102%-137% year-on-year, driven by strong revenue growth and cost control.